381 related articles for article (PubMed ID: 16878148)
1. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas.
Lin R; Maeda S; Liu C; Karin M; Edgington TS
Oncogene; 2007 Feb; 26(6):851-8. PubMed ID: 16878148
[TBL] [Abstract][Full Text] [Related]
2. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.
Panzitt K; Tschernatsch MM; Guelly C; Moustafa T; Stradner M; Strohmaier HM; Buck CR; Denk H; Schroeder R; Trauner M; Zatloukal K
Gastroenterology; 2007 Jan; 132(1):330-42. PubMed ID: 17241883
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel gene HEPT3 that is overexpressed in human hepatocellular carcinoma and may function through its noncoding RNA.
Moh MC; Lee LH; Yang X; Shen S
Int J Oncol; 2007 Aug; 31(2):293-301. PubMed ID: 17611685
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma.
Yagyu R; Hamamoto R; Furukawa Y; Okabe H; Yamamura T; Nakamura Y
Int J Oncol; 2002 Jun; 20(6):1173-8. PubMed ID: 12011995
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.
Guo Y; Chen Y; Ito H; Watanabe A; Ge X; Kodama T; Aburatani H
Gene; 2006 Dec; 384():51-61. PubMed ID: 16971064
[TBL] [Abstract][Full Text] [Related]
6. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
7. VCC-1, a novel chemokine, promotes tumor growth.
Weinstein EJ; Head R; Griggs DW; Sun D; Evans RJ; Swearingen ML; Westlin MM; Mazzarella R
Biochem Biophys Res Commun; 2006 Nov; 350(1):74-81. PubMed ID: 16989774
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma.
Zhang SH; Xu AM; Chen XF; Li DH; Sun MP; Wang YJ
Hum Pathol; 2008 Dec; 39(12):1827-34. PubMed ID: 18715617
[TBL] [Abstract][Full Text] [Related]
10. Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma.
Ip WK; Lai PB; Wong NL; Sy SM; Beheshti B; Squire JA; Wong N
Cancer Lett; 2007 Jun; 250(2):284-91. PubMed ID: 17126992
[TBL] [Abstract][Full Text] [Related]
11. Structural characterization and modeling of ncRNA-protein interactions.
Nacher JC; Araki N
Biosystems; 2010 Jul; 101(1):10-9. PubMed ID: 20206662
[TBL] [Abstract][Full Text] [Related]
12. Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis.
Kornek M; Raskopf E; Tolba R; Becker U; Klöckner M; Sauerbruch T; Schmitz V
Liver Int; 2008 Apr; 28(4):509-18. PubMed ID: 18339078
[TBL] [Abstract][Full Text] [Related]
13. [Comparative genomic classification of human hepatocellular carcinoma].
Kaposi-Novák P
Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma.
Lee NP; Leung KW; Cheung N; Lam BY; Xu MZ; Sham PC; Lau GK; Poon RT; Fan ST; Luk JM
Proteomics; 2008 May; 8(10):2136-49. PubMed ID: 18425728
[TBL] [Abstract][Full Text] [Related]
15. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.
Lu X; Feng X; Man X; Yang G; Tang L; Du D; Zhang F; Yuan H; Huang Q; Zhang Z; Liu Y; Strand D; Chen Z
Clin Cancer Res; 2009 May; 15(10):3287-96. PubMed ID: 19447873
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
17. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic significance of the alpha B-crystallin gene in human hepatocellular carcinoma.
Tang Q; Liu YF; Zhu XJ; Li YH; Zhu J; Zhang JP; Feng ZQ; Guan XH
Hum Pathol; 2009 Mar; 40(3):300-5. PubMed ID: 18992912
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
Kim CJ; Song JH; Cho YG; Cao Z; Lee YS; Nam SW; Lee JY; Park WS
Histopathology; 2008 Apr; 52(5):552-9. PubMed ID: 18312352
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon.
Lukasiak S; Schiller C; Oehlschlaeger P; Schmidtke G; Krause P; Legler DF; Autschbach F; Schirmacher P; Breuhahn K; Groettrup M
Oncogene; 2008 Oct; 27(46):6068-74. PubMed ID: 18574467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
